Patient Receives World’s First and Only 365-Day Continuous Glucose Monitor

Chris Walker becomes the first patient to receive a new technology to help him manage his diabetes. The procedure is at Mercy Hospital St. Louis.

“I haven’t been able to control my diabetes in several years,” said Walker. “And then Dr. Weike had talked to me about this several months ago.”

Senseonics’ next-generation Eversense® 365 system is the world’s first and only 365-day continuous glucose monitor. Walker is the very first patient to receive the implantable device when it became commercially available.

“We had the opportunity to embrace innovation and be the first in the world to place a continue glucose device that’ll last 12 months for a patient with type 2 diabetes,” said Ray Weike, MD, Regional Physician Executive and Family Physician at Mercy.

The long-term monitoring solution empowers patients with real-time data and enables clinicians to deliver proactive and personalized care. And it’s designed to give patients long-term peace of mind and enhanced quality of life.

#diabetes #diabetesawareness #diabetesmanagement #diabetescare #glucosecontrol #glucose #glucosemonitoring